Epidemiology and Data Science, Amsterdam UMC location Vrije Universiteit Amsterdam, de Boelelaan 1117, Amsterdam, Netherlands.
Quality of Care, Amsterdam Public Health, Amsterdam, The Netherlands.
Syst Rev. 2022 Jun 13;11(1):121. doi: 10.1186/s13643-022-01994-5.
Systematic reviews of outcome measurement instruments are important tools in the evidence-based selection of these instruments. COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) has developed a comprehensive and widespread guideline to conduct systematic reviews of outcome measurement instruments, but key information is often missing in published reviews. This hinders the appraisal of the quality of outcome measurement instruments, impacts the decisions of knowledge users regarding their appropriateness, and compromises reproducibility and interpretability of the reviews' findings. To facilitate sufficient, transparent, and consistent reporting of systematic reviews of outcome measurement instruments, an extension of the PRISMA (Preferred Reporting of Items for Systematic reviews and Meta-Analyses) 2020 guideline will be developed: the PRISMA-COSMIN guideline.
The PRISMA-COSMIN guideline will be developed in accordance with recommendations for reporting guideline development from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. First, a candidate reporting item list will be created through an environmental literature scan and expert consultations. Second, an international Delphi study will be conducted with systematic review authors, biostatisticians, epidemiologists, psychometricians/clinimetricians, reporting guideline developers, journal editors as well as patients, caregivers, and members of the public. Delphi panelists will rate candidate items for inclusion on a 5-point scale, suggest additional candidate items, and give feedback on item wording and comprehensibility. Third, the draft PRISMA-COSMIN guideline and user manual will be iteratively piloted by applying it to systematic reviews in several disease areas to assess its relevance, comprehensiveness, and comprehensibility, along with usability and user satisfaction. Fourth, a consensus meeting will be held to finalize the PRISMA-COSMIN guideline through roundtable discussions and voting. Last, a user manual will be developed and the final PRISMA-COSMIN guideline will be disseminated through publications, conferences, newsletters, and relevant websites. Additionally, relevant journals and organizations will be invited to endorse and implement PRISMA-COSMIN. Throughout the project, evaluations will take place to identify barriers and facilitators of involving patient/public partners and employing a virtual process.
The PRISMA-COSMIN guideline will ensure that the reports of systematic reviews of outcome measurement instruments are complete and informative, enhancing their reproducibility, ease of use, and uptake.
系统评价是基于证据选择这些工具的重要工具。COSMIN(健康测量工具选择的共识标准)制定了一项全面而广泛的指南,用于进行系统评价的结果测量工具,但发表的综述中经常缺少关键信息。这阻碍了对结果测量工具质量的评估,影响了知识使用者对其适宜性的决策,并损害了综述结果的可重复性和可解释性。为了促进充分、透明和一致地报告结果测量工具的系统评价,将扩展 PRISMA(系统评价和荟萃分析的首选报告项目)2020 指南:PRISMA-COSMIN 指南。
PRISMA-COSMIN 指南将按照 EQUATOR(提高卫生研究的质量和透明度)网络的报告指南制定建议制定。首先,通过环境文献扫描和专家咨询创建候选报告项目清单。其次,将与系统评价作者、生物统计学家、流行病学家、心理测量学家/临床计量学家、报告指南制定者、期刊编辑以及患者、护理人员和公众进行国际 Delphi 研究。Delphi 小组成员将根据纳入的 5 分制对候选项目进行评分,提出其他候选项目,并就项目措辞和可理解性提供反馈。第三,将通过将其应用于几个疾病领域的系统评价来迭代试点 PRISMA-COSMIN 指南和用户手册,以评估其相关性、全面性和可理解性,以及可用性和用户满意度。第四,将通过圆桌讨论和投票举行共识会议,最终确定 PRISMA-COSMIN 指南。最后,将制定用户手册,并通过出版物、会议、通讯和相关网站传播最终的 PRISMA-COSMIN 指南。此外,将邀请相关期刊和组织认可和实施 PRISMA-COSMIN。在整个项目中,将进行评估,以确定涉及患者/公众合作伙伴的障碍和促进因素,并采用虚拟流程。
PRISMA-COSMIN 指南将确保结果测量工具的系统评价报告完整且信息丰富,从而提高其可重复性、易用性和采用率。